Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
745.69 | -45.65% | -23.35% | 654,235.43 | 0.71% | 3.59% |
|
NYSE:JNJ
Johnson & Johnson
|
149.56 | 0% | 0% | 356,431.01 | 3.33% | 3.91% |
|
NYSE:PFE
Pfizer
|
26.32 | 19.53% | 52.98% | 147,226.07 | 6.4% | -9.31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
404.91 | 10.54% | 19.29% | 101,905.35 | 0% | 30.14% |
|
NYSE:BMY
Bristol-Myers Squibb
|
48.99 | 45.57% | 54.87% | 99,169.3 | 4.88% | 13.54% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
907.32 | -22.88% | -16.31% | 96,373.98 | 0% | 13.9% |
|
NYSE:ZTS
Zoetis
|
149.56 | 50.35% | 68.97% | 66,942.77 | 1.19% | 11.57% |
|
NYSE:BAX
Baxter International Inc
|
41.02 | 63.14% | 87.8% | 20,103.93 | 2.87% | -3.14% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
146.07 | 0% | 0% | 18,260.95 | 0% | 0% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.36 | 4.85% | 15.35% | 13,360.15 | 4.27% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
234.47 | -0.15% | 10.33% | 11,196.64 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
56.03 | -57.01% | -6.2% | 10,040.45 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
65.57 | 0% | 0% | 7,941.36 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
41.84 | -,150.35% | -,143.74% | 6,374.47 | 0% | 0% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
218.38 | 0% | 0% | 5,006.79 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
145.07 | -0.18% | 9.42% | 4,629.66 | 0.55% | 4.44% |
|
NasdaqGS:NEOG
Neogen
|
12.31 | 150.05% | 256.55% | 2,514.82 | 0% | -1.7% |
|
LSE:INDV
Indivior PLC
|
15.20 | -20.52% | 2.31% | 1,934.27 | 0% | -8.91% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
23.00 | -30.32% | -4.82% | 2,383.06 | 0% | 2.03% |
|
NasdaqGS:IRWD
Ironwood Pharmaceuticals
|
8.31 | -52.37% | -35.9% | 2,340.37 | 0% | 0% |
